This compound is a sulfonylurea derivative investigated as a pharmaceutical intermediate. It features an aromatic amide structure with ether and halogen substituents.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 16673-34-0
O-((guanin-9-yl)methyl) acyclovir
pharmaceutical intermediate
Glycinamide hydrochloride
pharmaceutical intermediate
Fmoc-N-(2,4-dimethoxybenzyl)-Gly-OH
pharmaceutical intermediate
N-Fmoc-N-(2,4,6-trimethoxybenzyl)glycine
pharmaceutical intermediate
Methyl 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoate
pharmaceutical intermediate
Bezafibrate
pharmaceutical raw material
N-Benzoyl-DL-tyrosil-N',N'-dipropylamide
pharmaceutical intermediate
N--[4-(1-Methylethyl)benzoyl]-D-phenylalanine
pharmaceutical intermediate
5-chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide
KVWWTCSJLGHLRM-UHFFFAOYSA-N
COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N